Aplastic Anaemia

Publications


To see AAWP Updates written for the EBMT News click here

Stern M, Passweg JR, Locasciulli A, Socie G, Schrezenmeier H, Bekassy AN, Fuehrer M, Hows J, Korthof ET, McCann S, Tichelli A, Zoumbos NC, Marsh JC, Bacigalupo A, Gratwohl A; for the Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation. Influence of Donor/Recipient Sex Matching on Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Aplastic Anemia Transplantation 2006;82:000–000)

A Bacigalupo ,F Locatelli ,G Dini ,J Marsh ,G Socié ,S Maury ,A Locasciulli ,S Cesaro ,J Passweg. Fludarabine , Cyclophosphamide And Anti-Thymocyte Globulin (Atg) For Alternative Donor Transplants In Acquired Aplastic Anemia (Saa): A Report From The Ebmt-Saa Working Party. Bone Marrow Transplant 2005 (epub)

Cesaro S, Oneto R, Messina C, Gibson BE, Buzyn A, Steward C, Gluckman E, Breddius R, Boogaerts M, Vermylen C, Veys P, Marsh J, Badell I, Michel G, Gungor T, Niethammer D, Bordigoni P, Oswald C, Favre C, Passweg J, Dini G; the EBMT Severe Aplastic Anaemia and Paediatric Diseases Working Party. Haematopoietic stem cell transplantation for Shwachman-Diamond disease: a study from the European Group for blood and marrow transplantation. Br J Haematol. 2005 Oct;131(2):231-6.

H. Schrezenmeier, C. Bredeson, B. Bruno et al. Comparison of allogeneic bone marrow and peripheral blood stem cell transplantation for aplastic anaemia. Blood. 2003

Tichelli A., Socie G., Marsh J., Barge R., Frickhofen N., McCann S., Bacigalupo A., Hows J., Marin P., Nachbaur D., Symeonidis A., Passweg J., Schrezenmeier H.; European Group for Blood and Marrow Transplantation Severe Aplastic Anaemia Working Party. Outcome of pregnancy and disease course among women with aplastic anemia treated with immunosuppression. Ann. Intern. Med. 137:164-172, 2002

Bacigalupo A., Oneto R., Bruno B., Socie G., Passweg J., Locasciulli A., Van Lint M.T., Tichelli A., McCann S., Marsh J., Ljungman P., Hows J., Marin P., Schrezenmeier H. Current results of bone marrow transplantation in patients with acquired severe aplastic anemia. Report of the European Group for Blood and Marrow Transplantation. On behalf of the Working Party on Severe Aplastic Anemia of the European Group for Blood and Marrow Transplantation.Acta Haematol. 103:19-25, 2000

Locatelli F;Bruno B;Zecca M;Van Lint MT;McCann S;Arcese W;Dallorso S;Di Bartolomeo P;Fagioli F;Locasciulli A;Lawler M;Bacigalupo A. Cyclosporin A and short-term methotrexate versus cyclosporin A as graft versus host disease prophylaxis in patients with severe aplastic anemia given allogeneic bone marrow transplantation from an HLA-identical sibling: results of a GITMO/EBMT randomized trial. Blood 96:1690-1697, 2000

European Group for Blood and Marrow Transplantation (EBMT) Working Party on Severe Aplastic Anemia and the Gruppo Italiano Trapianti di Midolio Osseo (GITMO). Bacigalupo A;Bruno B;Saracco P;Di Bona E;Locasciulli A;Locatelli F;Gabbas A;Dufour C;Arcese W;Testi G;Broccia G;Carotenuto M;Coser P;Barbui T;Leoni P;Ferster A. Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients.Blood 95:1931-1934, 2000

Bacigalupo A, Brand R, Oneto R, Bruno B, Socié G, Passweg J, Locasciulli A, VanLint MT, Tichelli A, McCann S, Marsh JCW, Ljungman P, Hows J, Marin P, and Schrezenmeier H. Treatment of acquired severe aplastic anemia (SAA): Bone marrow transplantation (BMT) compared with immunsuppressive therapy (IS): a report of the European Group for Blood and Marrow Transplantation. Semin.Hematol. 37:69-80 2000.

Tichelli A, Socié G, Henry-Amar M, Marsh J, Passweg J, Schrezenmeier H, McCann S, Hows J, Ljungman P, Marin P, Raghavachar A, Locasciulli A, Gratwohl A, Bacigalupo A. Effectiveness of immunosuppressive therapy in older patients with aplastic anaemia. European Group for Blood and Marrow Transplantation Severe Aplastic Anaemia Working Party. Ann.Intern.Med. 130:193, 1999.

Schrezenmeier H and Bacigalupo A. Aplastic Anemia - Pathophysiology and Treatment. Cambridge University Press: Cambridge 1999.

Marsh J, Schrezenmeier H, Marin P, Ilhan O, Ljungman P, McCann S, Socié G, Tichelli A, Passweg J, Hows J, Raghavachar A, Locasciulli A, and Bacigalupo A. Prospective randomized multicenter study comparing cyclosporin alone versus the combination of antithymocyte globulin and cyclosporin for treatment of patients with nonsevere aplastic anemia: a report from the European Blood and Marrow Transplant (EBMT) Severe Aplastic Anaemia Working Party. Blood 93 (7):2191-2195, 1999.

Bacigalupo A, Schrezenmeier H, and Hows J. Treatment of acquired severe aplastic anemia (SAA) for the EBMT Working Party on SAA. International Journal of Pediatric Hematology/Oncology 4:267-274, 1999.

Raghavachar A, Bacigalupo A, and Schrezenmeier H. Use of filgrastim (r-metHuG-CSF) in aplastic anemia. In: Morstyn G, Dexter TM, and Foote MA (eds.) Filgrastim (r-metHuG-CSF) in clinical practice. Marcel Dekker, Inc: New York, Basel, Hong Kong 1998, pp 533-551.

Guardiola P, Socié G, Pasquini R, Dokal I, Ortega JJ, van Weel-Sipman M, Marsh J, Locatelli F, Souillet G, Cahn JY, Ljungman P, Miniero R, Shaw J, Vermylen C, Archimbaud E, Bekassy AN, Krivan G, Di Bartolomeo P, Bacigalupo A, and Gluckman E. Allogeneic stem cell transplantation for Fanconi Anaemia. Severe Aplastic Anaemia Working Party of the EBMT and EUFAR. European Group for Blood and Marrow Transplantation. Bone Marrow Transplant. 21 Suppl 2:S24-S27, 1998.

Socié G, Bacigalupo A, Devergie A, Carosella ED, and Gluckman E. Acquired aplastic anaemia: Optimum immunosuppressive treatment. Clin.Immunother. 4:9-15, 1995.

Hows J, Bacigalupo A, Downie T, and Brand R. Alternative donor bone marrow transplantation for severe aplastic anaemia: the European experience. In: Gluckman E, Coulombel L (eds.) Ontogeny of hematopoieis - Aplastic Anaemia. John Libbey Eurotext Ltd: London 1995, pp 331-334.

Bacigalupo A, Broccia G, Corda G, Arcese W, Carotenuto M, Gallamini A, Locatelli F, Mori PG, Saracco P, Todeschini G, et al. Antilymphocyte globulin, cyclosporin, and granulocyte colony- stimulating factor in patients with acquired severe aplastic anemia (SAA): a pilot study of the EBMT SAA Working Party. Blood 85 (5):1348-1353, 1995.

McCann SR, Bacigalupo A, Gluckman E, Hinterberger W, Hows J, Ljungman P, Marin P, Nissen C, van't Veer Kerthof E, Raghavachar A., Socié G, Frickhofen N, Locasciulli A, and Schrezenmeier H. Graft rejection and second bone marrow transplants for acquired aplastic anaemia: a report from the Aplastic Anaemia Working Party of the European Bone Marrow Transplant Group. Bone Marrow Transplant. 13:233-237, 1994.

Marsh JC, Socié G, Schrezenmeier H, Tichelli A, Gluckman E, Ljungman P, McCann SR, Raghavachar A, Marin P, Hows JM, and et al. Haemopoietic growth factors in aplastic anaemia: a cautionary note. European Bone Marrow Transplant Working Party for Severe Aplastic Anaemia. Lancet 344:172-173, 1994.

Bacigalupo A. Guidelines for the treatment of severe aplastic anaemia. Working Party on Severe Aplastic Anemia (WPSAA) of the European Group of Bone Marrow Transplantation (EBMT). Haematologica 79:438-444, 1994.

Socié G, Henry Amar M, Bacigalupo A, Hows J, Tichelli A, Ljungman P, McCann SR, Frickhofen N, Van't Veer-Korthof E, and Gluckman E. Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party. N Engl J Med 329:1152-1157, 1993.

Schrezenmeier H and Bacigalupo A. Aplastic Anaemia. Bone Marrow Transplant. 12 (suppl.):S98-S100, 1993.

Schrezenmeier H, Marin P, Raghavachar A, McCann S, Hows J, Gluckman E, Nissen C, van't Veer Korthof ET, Ljungman P, Hinterberger W, Van Lint MT, Frickhofen N, and Bacigalupo A. Relapse of aplastic anaemia after immunosuppressive treatment: a report from the European Bone Marrow Transplantation Group SAA Working Party. Br.J.Haematol. 85:371-377, 1993.

Schrezenmeier H, Marin P, Raghavachar A, McCann S, Hows J, Gluckman E, Nissen C, van't Veer-Korthof ET, Ljungman P, Hinterberger W, Van Lint MT, and Bacigalupo A. Long-term follow up after immunosuppression: relapse of aplastic anaemia. A report of the EBMT SAA Working Party. In: Raghavachar A, Schrezenmeier H, and Frickhofen N (eds.): Aplastic Anemia - Current Perspectives on the Pathogenesis and Treatment. Blackwell-MZV: Vienna 1993, pp 144-152.

Bacigalupo A, Chaple M, Hows J, Van Lint MT, McCann S, Milligan D, Chessels J, Goldstone AH, Ottolander J, Van't Veer ET, Comotti B, Coser P, Broccia G, Bosi A, Locasciulli A, Catalano L, Battista R, Arcese W, Carotenuto M, Marmont AM, and Gordon Smith EC. Treatment of aplastic anaemia (AA) with antilymphocyte globulin (ALG) and methylprednisolone (MPred) with or without androgens: a randomized trial from the EBMT SAA working party. Br.J.Haematol. 83:145-151, 1993.

Socié G, Henry-Amar M, Hows J, Ljungman P, Gluckman E, and Bacigalupo A. Assessment of malignant tumour risk after treatment for severe aplastic anaemia (SAA): a study of the EBMT-SAA Working Party. b Stockholm: 1992. (Abstract)

Locasciulli A, van't Veer L, Bacigalupo A, Hows J, Van Lint MT, Gluckman E, Nissen C, McCann S, Vossen J, Schrezenmeier H, Hinterberger W, and Marin P. Treatment with marrow transplantation or immunosuppression of childhood acquired severe aplastic anemia: a report from the EBMT SAA Working Party. Bone Marrow Transplant. 6:211-217, 1990.

Locasciulli A, van't Veer ET, Hows J, Van Lint MT, Gluckman E, Nissen C, McCann S, Vossen J, Schrezenmeier H, Hinterberger W, Marin P, and Bacigalupo A. Bone marrow transplantation (BMT) in children with severe aplastic anaemia (SAA) from donors other than HLA identical siblings. EBMT Working Party on Severe Aplastic Anaemia. Bone Marrow Transplant. 7 Suppl 3:90-91, 1991.

Locasciulli A, Vossen J, Bacigalupo A, Hows J, VanLint MT, Gluckman E, Nissen C, McCann S, de Planque M, van'tVeer L, et al. Allogeneic bone marrow transplantation (BMT) for acquired severe aplastic anaemia (SAA) in children. Bone Marrow Transplant. 4 Suppl 4:123-125, 1989.

De Planque MM, Bacigalupo A, Wursch A, Hows JM, Devergie A, Frickhofen N, Brand A, and Nissen C. Long-term follow-up of severe aplastic anaemia patients treated with antithymocyte globulin. Severe Aplastic Anaemia Working Party of the European Cooperative Group for Bone Marrow Transplantation (EBMT). Br.J.Haematol. 73:121-126, 1989.

Bacigalupo A, Hows J, Gluckman E, Nissen C, Marsh J, Van Lint MT, Congiu M, De Planque MM, Ernst P, McCann S, Raghavachar A, Frickhofen N, Würsch A, Marmont AM, and Gordon-Smith EC. Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT SAA working party. Br.J.Haematol. 70:177-182, 1988.

Bacigalupo A, Hows J, Gordon Smith EC, Gluckman E, Van Lint MT, Congiu M, James DC, Barrett AJ, Gmur J, De Planque MM, et al. Bone marrow transplantation for severe aplastic anemia from donors other than HLA identical siblings: a report of the BMT Working Party. Bone Marrow Transplant. 3:531-535, 1988.

EBMT News Updates (Click on the pdf symbol)

March 2005